HIT Consultant October 22, 2024
Christopher Wooden, Senior Director, Business Marketing, IQVIA

A critical aspect of any pharma/life sciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs). A brand can best meet its clinical and commercial objectives throughout its lifecycle by offering a well-orchestrated mix of information and resources in different digital and in-person formats that HCPs can easily access.

As with any multifaceted marketing and commercialization strategy, brand teams must identify and track the most relevant metrics to measure the impact of these programs. The main objective is to ensure all program elements are designed and delivered in a way that meets the specific needs and preferences of individual HCPs.

Results from a recent survey of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Precision Medicine Hinges On Access To Genetic Counselors
RNA editing: emerging from CRISPR’s shadow
Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D
Dotmatics aims to speed drug development, break data silos with Geneious Luma
1st sickle cell gene therapy patient completes treatment

Share This Article